Literature DB >> 23404094

Microglial-neuronal interactions during neurodegenerative diseases.

Carol A Colton1.   

Abstract

The impact of the brain's immune response to disease is no longer relegated to a secondary event of limited interest. Multiple types of brain and spinal cord injuries and diseases show varying immune phenotypes over the time course of the disease. The collection of articles illustrates the wide reach of brain immunity and provides research papers and reviews that illustrate this point. These articles have added both new information and new directions to consider, and I would like to thank all of the participants for their insightful contributions to the field.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23404094      PMCID： PMC3652666          DOI： 10.1007/s11481-013-9437-9

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN： 1557-1890            Impact factor:   4.147


  22 in total

1.  Fighting off pain with resolvins.

Authors:  Claudia Sommer; Frank Birklein
Journal:  Nat Med       Date:  2010-05       Impact factor: 53.440

Review 2.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 3.  Type I interferon response in the central nervous system.

Authors:  Sophie Paul; Céline Ricour; Caroline Sommereyns; Frédéric Sorgeloos; Thomas Michiels
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

4.  Study of the transformation of amoeboid microglial cells into microglia labelled with the isolectin Griffonia simplicifolia in postnatal rats.

Authors:  C Kaur; E A Ling
Journal:  Acta Anat (Basel)       Date:  1991

5.  Development of the various glial cell types in the cerebral cortex of postnatal rats.

Authors:  C Kaur; E A Ling; W C Wong
Journal:  Acta Anat (Basel)       Date:  1989

6.  Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline.

Authors:  Staci D Bilbo
Journal:  Neurobiol Learn Mem       Date:  2010-04-11       Impact factor: 2.877

Review 7.  Fatty acid oxidation in the pathogenesis of Alzheimer's disease.

Authors:  Thomas J Montine; Jason D Morrow
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

8.  Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain.

Authors:  Sondra T Bland; Jacob T Beckley; Sarah Young; Verne Tsang; Linda R Watkins; Steven F Maier; Staci D Bilbo
Journal:  Brain Behav Immun       Date:  2009-09-25       Impact factor: 7.217

Review 9.  Emerging roles of PGE2 receptors in models of neurological disease.

Authors:  Katrin Andreasson
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-11       Impact factor: 3.072

Review 10.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147
View more
  6 in total

1.  Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects.

Authors:  Dong-Hui Chen; Alipi Naydenov; Jacqueline L Blankman; Heather C Mefford; Marie Davis; Youngmee Sul; A Samuel Barloon; Emily Bonkowski; John Wolff; Mark Matsushita; Corrine Smith; Benjamin F Cravatt; Ken Mackie; Wendy H Raskind; Nephi Stella; Thomas D Bird
Journal:  Hum Mutat       Date:  2013-10-02       Impact factor: 4.878

Review 2.  The nervous and the immune systems: conspicuous physiological analogies.

Authors:  Julio Sotelo
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-11-15       Impact factor: 1.836

3.  Immunomodulatory function of κ-carrageenan oligosaccharides acting on LPS-activated microglial cells.

Authors:  Zi-Ang Yao; Ling Xu; Hai-Ge Wu
Journal:  Neurochem Res       Date:  2013-12-20       Impact factor: 3.996

Review 4.  Signaling and stress: The redox landscape in NOS2 biology.

Authors:  Douglas D Thomas; Julie L Heinecke; Lisa A Ridnour; Robert Y Cheng; Aparna H Kesarwala; Christopher H Switzer; Daniel W McVicar; David D Roberts; Sharon Glynn; Jon M Fukuto; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

5.  Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats.

Authors:  Xiao-Qian Li; Jun Wang; Bo Fang; Wen-Fei Tan; Hong Ma
Journal:  Mol Brain       Date:  2014-04-21       Impact factor: 4.041

6.  The role of the immunoproteasome in interferon-γ-mediated microglial activation.

Authors:  Kasey E Moritz; Nikki M McCormack; Mahlet B Abera; Coralie Viollet; Young J Yauger; Gauthaman Sukumar; Clifton L Dalgard; Barrington G Burnett
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.